There’s a new face at the head of one of metro Atlanta’s biopharmaceutical companies.

Alpharetta-based Clearside Biomedical Inc. (NASDAQ: CLSD) announced that George Lasezkay has been appointed president and CEO after serving as interim CEO since April 2019.

Lasezkay succeeded Daniel H. White, who resigned as president, CEO and a member of the Clearside board to pursue other opportunities. Lasezkay’s appointment was effective March 1.

Alpharetta-based Clearside Biomedical Inc. also announced…

Atlanta Business Journal
Eye disease pharmaceutical company makes change at top permanent